Use of suppression subtractive hybridization to identify genes regulated by ciliary neurotrophic factor in postnatal retinal explants by Roger, Jérôme et al.
 Molecular Vision 2007; 13:206-19 <http://www.molvis.org/molvis/v13/a24/>
Received 2 November 2006 | Accepted 31 January 2007 | Published 7 February 2007
 The generation of the seven major cell types of neural
retina follows an evolutionarily conserved temporal sequence,
in which retinal progenitors progressively exit the cell cycle
and subsequently differentiate in all cell types of an adult retina.
Ganglion cells, cone photoreceptors, horizontal cells, and the
majority of amacrine cells are born during early histogenesis,
whereas bipolar cells, Müller glia, and the majority of rod
photoreceptors are born during late histogenesis [1-3]. The
retinal progenitors are multipotent, and the decision taken by
a progenitor to differentiate along a particular path depends
on both cell-intrinsic and cell-extrinsic factors [2-5]. In vitro
culture or co-culture experiments have demonstrated that the
differentiation of retinal progenitors can be influenced by epi-
genetic cues such as diffusible factors liberated by differenti-
ated cells or cells undergoing differentiation and exogenously
added factors [6-9].
It has been demonstrated that retinal progenitors, and more
recently retinal stem cells, retain the ability to differentiate
into any retinal cell type, in particular photoreceptors. Thus,
these cells offer a promising approach to cure retinal dystro-
phies and restore visual function in a postmitotic environment
such as central nervous system. However, experiments dem-
onstrate that despite the engraftment of these cells in the re-
cipient retina, where they express some retinal markers (in
particular photoreceptor markers), they fail to undergo final
differentiation and, in the case of photoreceptors, don’t ex-
hibit outer segment differentiation [10]. In contrast to stem
cells and embryonic retinal precursors, it has been recently
reported [11] that rod precursors (derived from P1 to P7 mouse
retina) effectively incorporate into the outer nuclear layer of a
wild-type or a degenerating retina where they establish func-
tional synapses with cells from the inner nuclear layer (INL).
Therefore, to achieve a more complete in vivo differentiation,
the mechanism by which photoreceptor differentiation occurs
during retinal development needs to be further elucidated. This
characterization may be possible by a careful examination of
the transcriptome modification during normal development,
however, it may be more readily achieved by the analysis of
changes in the retinal transcriptome subsequent to the modifi-
cation of retinal progenitor fate by exogenous cues. Numer-
ous cytokines including fibroblast growth factor (FGF), trans-
forming growth factor β (TGFβ), and taurine, have been de-
scribed as modifying the development of retina [9]. Among
possible cytokines, ciliary neurotrophic factor (CNTF), a mem-
ber of the IL-6 family was chosen based on its ability to act as
a neuroprotective factor on differentiated cells [12] and to af-
fect late retinal neurogenesis (i.e. photoreceptors cells).
CNTF has been described during rodent retinal develop-
ment, as having an influence on late retinal progenitor fate (in
particular a strong inhibition of rod photoreceptor cell differ-
entiation) [13-15], enhancing the expression of bipolar neu-
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ronal markers in rat retinal cultures [13,15,16] and promoting
Müller glia genesis from the postnatal retinal progenitor pool
[17].
In this study, we took advantage of the effect of CNTF on
retinal differentiation to identify transcripts whose expression
was up- or downregulated during CNTF-induced changes in
retinal cell fate, in particular during the inhibition of photore-
ceptor differentiation. Retinas were cultured as explants at
postnatal day 0 (P0) in the absence or presence of CNTF, and
transcripts regulated by CNTF after six days were selected by
subtraction suppressive hybridization (SSH) and cloned as two
libraries: for genes up- or downregulated by CNTF. A differ-
ential analysis process revealed eight clones as potential CNTF
upregulated genes and 21 as potential CNTF downregulated
genes. The aim of our study was to identify genes that pro-
mote photoreceptor cell differentiation from progenitor cells;
we therefore focused on genes downregulated by CTNF. We
explored their expression pattern by real-time PCR on cDNA
obtained from retinal explants cultured up to 9 days after ad-
dition of either CNTF or leukemia inhibitory factor (LIF). The
latter is a CNTF-like cytokine belonging to the IL-6 family,
having the same biological effect as CNTF [13,14]. Kinetic
expression of selected clones was also performed by real-time
PCR during rat retinal development. Their expression in Müller
cells and in photoreceptor cells was analyzed by real-time PCR,
respectively on cDNA obtained from rat Müller glial cell cul-
tures and in retina from control and dystrophic Royal College
of Surgeons rats (RCS).
METHODS
Retinal explant cultures:  Retinal tissues were derived from
newborn Sprague-Dawley OFA rats from Charles River
(L’Arbresle, France). The methods used to secure animal tis-
sue complied with the ARVO Statement for the Use of Ani-
mals in Ophthalmic and Vision Research. Newborn retina were
dissected in Hank’s Balanced sodium salts (HBSS) without
calcium and magnesium (Invitrogen, Cergy-Pontoise, France)
and then placed on polycarbonate filter discs (Dutscher S.A.,
Brumath, France) following directions previously described
[18]. Retinal explants were cultured in DMEM/F12 medium
(Invitrogen) with 10 mM Hepes pH=7 containing 5% fetal
calf serum (FCS) in the absence or in the presence of 10 ng/ml
of recombinant CNTF or LIF, purchased from R&D Systems
Europe (Lille, France). The medium was changed every three
days. After a specified number of days in vitro, explants were
fixed for subsequent immunohistochemistry studies or re-
moved for RNA preparation. In this latter case, for each time
points, three independent explants were detached from the fil-
ters, pooled and washed in PBS without calcium and magne-
sium before undergoing homogenization in lysis buffer sup-
plied in Nucleospin RNAII kit (Macherey-Nagel, Hoerdt,
France).
Immunostaining:  Retinal explant sections were fixed 5
min with 4% paraformaldehyde in PBS before immunostaining
with monoclonal antibody against GFAP (Sigma, L’Isle-
d’Abeau, France) following previously described procedure
[18].
Müller glial cell cultures:  Pure glial cells cultures were
prepared from Sprague Dawley rats at postnatal day 10 as
described by Goureau et al. [19]. Briefly, eyeballs were incu-
bated in Dulbecco’s modified eagle medium (DMEM) con-
taining 0.2% trypsin and 100 U/ml collagenase at 37 °C for
60 min. The globes were dissected to separate the neural retina
from the posterior segment and retinas were cut into small
fragments and plated in DMEM supplemented with 10% FCS
and 2 mM glutamine. After 3-4 days, fragments were removed
by extensive rinsing with phosphate buffer saline (PBS), and
the remaining flat cell population incubated with fresh DMEM.
Primary cell cultures or cells of passages 1-3 were used for
experiments.
RNA isolation and RT-PCR:  Total RNA extracted from
retinal explants, Müller cell cultures or retina from adult RCS
rats were digested by DNaseI (Invitrogen) according to the
manufacturer’s recommendations. Total RNA were reverse
transcribed in presence of oligo-dT using the following proto-
col. Denaturation of 1 µg of RNA was performed for 5 min,
which was then reverse transcribed into cDNA by incubation
with 1 µl of deoxyribonucleoside triphosphate solution (dNTP;
10 mM of dATP, dCTP, dGTP, dTTP), 1 µl of oligo-dT (10
µM), 4 µl 5X reaction buffer, 2 µl of 0.1 M Dithiotreitol (DTT),
1 µl of RNasin and x200 U of superscript II (Invitrogen) to a
final volume of 20 µl. Samples were incubated for 50 min at
42°C and the enzyme inactivated at 70 °C for 15 min.
Subtraction suppressive hybridization and cDNA librar-
ies cloning:  The polyA RNAs for libraries cloning were ob-
tained from three independent retinal explant cultures. PolyA
RNAs were purified from retinal explants total RNA using
PolyATtract® mRNA Isolation System I according to the sup-
plied protocol (Promega, France). SSH libraries were gener-
ated using the reagents and protocols provided by Clontech
(Clontech, Palo Alto, CA); SSH select specific (differentially
expressed) transcripts present in a test cDNA population (re-
ferred to tester) and absent from a reference (referred to as
driver). The first step, two separate samples of tester cDNAs
ligated to different 5' adaptor are heat denatured and allowed
to anneal with an excess of driver. The concentration of high-
and low-abundance sequences is equalized among the single
strand cDNA molecules because reannealing is faster for the
more abundant molecules due to the second-order kinetics of
hybridization. At the same time, single strand cDNA is sig-
nificantly enriched for differentially expressed sequences.
During a second hybridization, the two primary hybridization
samples are mixed together without denaturation allowing the
single strand cDNA to reassociate and form new type hybrids
that can be amplified using primer specific to each 5' adaptor.
SSH products are cloned into pCRII-TOPO plasmid
(Invitrogen). In the first SSH library, UC6 (upregulated by
CNTF after 6DIV), RNA from CNTF-treated explants were
used as tester and RNA from control was used as driver. In the
second SSH library, DC6 (downregulated by CNTF after 6
days in vitro-6DIV), RNA from control explants were used as
driver and RNA from treated explants were used as tester. RT-
PCR analysis of the SSH products showed that the level of the
housekeeping gene GAPDH decreased more than 100 fold in
207both (UC6) and (DC6) cDNAs when compared with
unsubtracted cDNAs (data not shown), suggesting that the
subtraction procedure was effective.
Differential analysis process and clone selection:  For both
libraries, a three step analysis was performed. In a first round
of screening, 96 clones from each library were randomly col-
lected, grown, and SSH products were amplified by PCR us-
ing universal primers. These 96 cDNAs were spotted onto
nylon membrane and hybridized with respective subtracted
and unsubtracted probes. Clones were selected on the basis of
their hybridization pattern according to the manufacturer’s
instructions. Thereafter, a second round of selection was done
using a reverse Northern blot. Briefly, radiolabeled probes were
synthesized using cDNA obtained from treated and control
explants as template by the ready prime labeling kit accord-
ingly to the manufacturer’s instructions (GE Healthcare,
Saclay, France). cDNAs selected from the first round were
spotted onto new membranes and hybridized with the 32P la-
beled probes. After hybridization and washes, membranes were
exposed to Xomat film (Kodak, GE Healthcare Europe). Im-
ages were acquired using the GelDoc imaging system (Biorad,
France) and analyzed with Quantity One quantification soft-
ware. For each selected clone, the treated over control inten-
sity-ratio was calculated. Clones with a ratio of 1.5 or higher
were selected and considered as upregulated by CNTF, whereas
clones with a ratio of 0.5 or below were selected as
downregulated by CNTF. Finally, all selected clones were se-
quenced using the thermosequenase fluorescent kit from GE
Healthcare according to the manufacturer’s protocol, and run
on a Licor sequencer. Sequences were analyzed with
BaseImagIR v2.2 software (Licor, ScienceTech, Paris, France)
and submitted to BLAST searches of various online databases
to characterize genes corresponding to selected SSH products
and find identities to human, mouse, and rat sequences. These
included the National Center for Biotechnology Information
(NCBI; no redundant GenBank, European molecular biology
laboratory (EMBL), DNA data bank of Japan (DDBJ), and
protein data bank (PDB)), Express Sequence Tag (EST; no
redundant GenBank, EMBL, and DDBJ EST divisions), the
Ensembl Genome Browser, and the Institute for Genomic
Research (TIGR).
Quantification by real-time PCR:  Real-time PCR was
performed using an Applied Biosystems 7300 Real-Time PCR
System (Applied Biosystems, Foster City, CA). Real-time PCR
was performed with Platinum® Quantitative PCR SuperMix-
Uracil DNA glycosylase (SuperMix-UDG; Invitrogen) accord-
ing to the manufacturer’s instructions. Reactions were per-
formed in a 20 µl final volume with 1.25 µM primers, 0.4 µl
of a glycine conjugate of 5-carboxy-X-rhodamine,
succinimidyl ester (ROX), 2 µl of cDNA (1/10) and 10 µl of
Platinum® Quantitative PCR SuperMix-UDG containing
buffer, MgCl2, SYBR Green dye, and dNTP mix (with dUTP
instead of dTTP). Primers used are described in Table 1. A
typical amplification protocol included an initial incubation
of UDG at 50 °C to remove nonspecific amplification that
occurred during preparation of plates, a 95 °C initial denatur-
ation step for 2 min followed by 45 cycles with a 95 °C dena-
turation for 15 s, and an annealing/amplification at 60 °C for
1 min. Detection of the fluorescent product was carried out at
the end of the 60 °C extension period. The absence of nonspe-
cific products was confirmed by both the analysis of the melt
curves and electrophoresis in 2% agarose gels of the PCR prod-
ucts. All samples were run in triplicate and the fluorescence
threshold value (Ct) was determined using the 7300 system
software (Applied Biosystems). To adjust the difference of
concentration of RNA reverse transcribed, S26, a ribosomal
protein, was used as an internal control. Relative quantity was
evaluated by ratio of RNA expression of the target gene and
S26 [20], expressed in arbitrary unit. Unpaired student’s t-
tests were used to compare data (Statistica Software; StatSoft,
Créteil, France). Values of p<0.05 were considered to be sig-
nificant.
RESULTS
 We generated two rat retina subtracted libraries with the aim
of identifying genes whose expression is either up- or
downregulated by CNTF. mRNAs were collected from P0 rat
retinal explants and cultured with media alone or with CNTF
for 6 DIV. To identify genes upregulated by CNTF after 6
days, a library named UC6 was generated using mRNAs from
control explants as driver, whereas genes downregulated by
CNTF after six days were isolated in a library named DC6
made with CNTF-treated explants mRNAs as driver. The sub-
tractions were assessed by RT-PCR amplification of Gapdh, a
housekeeping gene for which the expression ex vivo is not
influenced by the addition of CNTF. Gapdh were not ampli-
fied from the two subtracted SSH-cDNAs from 18 to 33 cycles
of amplification, whereas it could be amplified with as few as
18 cycles of PCR amplification from nonsubtracted cDNAs
(data not shown). The kinetics of Gapdh amplification clearly
indicated that subtractions were effective.
Following library screening, we isolated eight clones from
the UC6 library as potential CNTF upregulated genes and 21
from the DC6 library as potential CNTF downregulated genes.
In both libraries several genes were represented by more than
one clone indicating the likelihood that the totality of UC6
and DC6 cDNA had been screened. In the UC6 library, the
mean size of the cDNA was 421 base pairs and 474 in the
DC6 library. This small size was due to the requirement of an
enzymatic restriction of cDNA during the library cloning steps
for a proper normalization and subtraction of cDNA. Most of
the clones were located within the 3' UTR of their correspond-
ing gene. The 29 selected clones were sequenced and submit-
ted to databases to search homology with known rat sequences
and to find the human and mouse orthologues. Results are
shown in Table 2 and Table 3. All accession numbers refer to
NCBI databases.
Identification of genes isolated from UC6 library:  Re-
peated screening steps allowed the isolation of eight poten-
tially upregulated cDNAs in the UC6 library. These eight
cDNAs were sequenced and submitted to on-line databases to
determine their corresponding genes (Table 2). Among them,
two cDNAs (9H and 7E) represented a unique known gene,
four cDNAs (2G, 4F, 6H and 10A) were, respectively identi-
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208cal to four different known genes whereas two cDNAs (1H
and 3B) had only low identity to known genes or putative
genes. 1H, a RNA binding motif protein, and 3B which was
similar to a RIKEN cDNA, were not analyzed, since they did
not appear to be relevant to our study due to their low homol-
ogy to known genes. Taken together, five genes were found as
potentially upregulated by CNTF at 6DIV. This relatively small
number of genes didn’t allow a relevant classification using
the Gene Ontology Annotation (GOA).
To ensure that candidate genes were indeed regulated by
the CNTF family of cytokines, explants were collected after
6DIV with or without CNTF or LIF in conditions similar to
those used for library cloning. Their RNAs were isolated and
subjected to reverse transcription followed by real-time PCR
amplification. The expression of the five genes was further
characterized; results are presented in Figure 1.
9H and 7E cDNAs were identical to glial fibrillary acidic
protein (Gfap) sequence, which is known to be expressed in
activated Müller glial cells [21] and induced by CNTF in adult
retina [22,23]. Consistent with CNTF-induced Müller cell dif-
ferentiation [17], real-time PCR experiments demonstrated that
Gfap transcripts were induced more than five fold by CNTF
in comparison to untreated explants after 6 DIV. In the same
conditions, LIF treatment led to a 3.2 fold increase in Gfap
expression (Figure 1). To confirm the induction of Gfap in
Müller glial cells by CNTF and LIF, we took flat mounted
retinal explants from P0 rats and cultured them in conditions
similar to those used for RNA collection. We then analyzed
them by immunohistochemistry with a GFAP antibody. In
untreated explants (Figure 2B,C), a weak staining was only
observed in astrocytes located in the ganglion cell layer, as
previously described in retinal sections [22], whereas Müller
cells were completely negative. Consistent with real-time PCR
data, GFAP staining in the INL was largely increased after the
addition of CNTF (Figure 2E,F) or LIF (Figure 2H,I) com-
pared to untreated explants. The lamination of the retina is
conserved in the control untreated retina (Figure 2A) after
6DIV as well as after CNTF or LIF treatment for six days
(Figure 2D,G).
Clone 6H contained a whole coding sequence and corre-
sponded to a secreted protein named pleiotrophine (PTN), also
known as HB-GAM for heparin-binding growth-associated
molecule [24]. PTN has been involved in neurogenesis by pro-
motion of neurite outgrowth, nerve cell migration [25,26], and
regulation of stem cell proliferation and differentiation [27,28].
Real-time PCR experiments performed at 6DIV demonstrated
that CNTF or LIF induced Ptn by 35% and 45%, respectively
(Figure 1). Due to its biological function, Ptn appeared as a
candidate gene in mediating CNTF effects on retinal progeni-
tor differentiation. Furthermore as a secreted protein, PTN may
be a newly identified exogenous factor capable of modifying
the retinal progenitor differentiation as stated in our screen
objectives. For these reasons, the characterization of its func-
tion during retinal development was given priority. We have
recently demonstrated that PTN is involved in the biological
effects of CNTF, leading to the inhibition of rod photorecep-
tor differentiation and has a major role in the increase of bipo-
lar cell differentiation [18].
The 4F clone is a homolog of the oncostatin M (OSM)
receptor (Osmrβ) sequence. The OSM receptor is a dimeric
receptor composed of the gp130 subunit and the OSMRβ sub-
unit, specific to OSM. The other members of the CNTF fam-
ily (i.e. CNTF or LIF) do not bind to this receptor whereas
OSM is capable of binding to either the gp130/OSMRβ or the
gp130/LIFRβ complex [29]. Real time PCR experiment per-
formed at 6DIV demonstrated that the expression of this sub-
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TABLE 1. PRIMER SETS AGAINST RAT SEQUENCE CORRESPONDING TO
CDNAS IDENTIFIED BY SUBTRACTION SUPPRESSIVE HYBRIDIZATION
              UC6 Library                          DC6 Library
        -------------------------            --------------------------
Clone      Rat sequence (5'-3')     Clone        Rat sequence (5'-3')
-----   -------------------------   ------   --------------------------
9H      F: CTCAATGCCGGCTTCAAAGAG    F5       F: CAGCAGTGACCACCAACTGTC
        R: CGAAGTTCTGCCTGGTAAACG             R: ATCAAACCAAAACCCTTAGGGG
6H      F: GACTCAGAGATGTAAGATCCC    G4       F: TCTTGTATGAGGACTCCGTGC
        R: TGTGCAGAGCTCTCTTCAGAC             R: GGTACAAGAGCCAGCAGCATA
4F      F: ACCCACTAAGCCTCCATTGG     E2       F: CAGAGTCTCCTTTGCCTGAG
        R: GGTCCTGGAATGAAGCCATG              R: GGTATGGATCCAACCCACTG
2G      F: TTCCAGCTTGAAAGCCCAGCC    D2       F: CAAGAGGGCCATCTGTACCA
        R: TGACTCCGGGCTTGTGCGTAA             R: TTCAGGCACGGATGCAGATG
10A     F: GGCGCCTGCGATTAGTGCTACA   A7       F: GGCAGAGGGCGCTTTAATTTC
        R: TGATCCTGCCCAGGCCAAAGA             R: AGTGTCAAGTTCTGCTCCCTG
                                    F2       F: ATCAATTATGAAAGTTTACTGCC
                                             R: GCTTTTCTTGGATTCATTTGTC
                                    D1       F: ATGCCTCCATGTGTAGTGCGG
                                             R: TTTTGGTTGGTTTGCCTAAAA
                                    C2       F: GAGATGTACTACTGCTCCAAGTG
                                             R: GTGGTTTATGCTGGCAAAGAG
                                    B6       F: ATGGAGATGAAGAAGAAGATTAAC
                                             R: TGTCACTAAGTTCCAACTTCCG
                                    B2       F: TGAATTTGGCTCAGGAGCTGC
                                             R: ACTCAGTGAGTCACAGGAGGA
                                    G7       F: CTGTGGGCTTACAGAGCCAAA
                                             R: ATGGCTGCTTCCCTCTATAGT
                                    C7       F: AGGAAGGAAGAGCCTCGTCGT
                                             R: AGGGTTGCTGCACTGTTACTA
                                    A2       F: TCCCCTGAACCTGAATGCCTGG
                                             R: CTCAGCAGACTGCCCGAGGAA
                                    S26      F: AAGTTTGTCATTCGGAACATT
                                             R: GATCGATTCCTGACAACCTTG
Clone denotes the cDNA number in the library, and rat sequence
represents forward and reverse primer pairs corresponding to the
cDNA. The primers were used to detect gene expression from mRNA
extracted from retinal explants or RNA from neonatal rats. DC6 in-
dicates down-regulated by CNTF after 6DIV, UC6 indicates up-regu-
lated by CNTF after 6DIV.
TABLE 2. GENES ISOLATED BY SUBTRACTIVE SUPPRESSIVE HYBRIDIZA-
TION IN A UC6 (UPREGULATED BY CILIARY NEUROTROPHIC FACTOR
AFTER SIX DAYS IN VITRO) LIBRARY
                                                          Accession
Clone   bp             Blast result              Symbol     number    Homo    Status
-----   ---   --------------------------------   ------   ---------   -----   ------
9H      234   Glial fibrillary acidic protein    Gfap     NM_017009   1554      V
6H      692   Pleiotrophin                       Ptn      NM_017066   2117      A
4F      270   Oncostatin M receptor              Osmr     AB167522    2972      A
2G      370   Nuclear Receptor coactivator 1     Ncoa1    XM_233944   7859      no
10A     609   Glycyl t-RNA synthase              Gars     BC088347    1547      no
1H      486   RNA binding motif protein          Rbmx     unknown     20494     R
3B      367   Similar to RIKEN cDNA 3930401K13   N/A      BC085931    12252     R
UC6 subtraction suppressive hybridization library was generated
using RNA from six days in vitro (6DIV)-ciliary neurotrophic factor
treated explants as tester and the RNA from control as driver. cDNAs
from this library were screened for differential expression and se-
quenced. Clone denotes the cDNA number in the library; bp repre-
sents the size in base pair of the cDNA; blast result indicates the
published sequence identical to the clone sequence; symbol, acces-
sion number and Homo refer to the available homologene on-line
datas for the published sequence. Status represents the cDNA char-
acterization in this study: A for analyzed, R for rejected, no for gene
that didn’t exhibit gene expression variation, and V for gene validat-
ing the library.
209unit was 2.1 fold higher when CNTF was added to explant
culture compared to a control culture whereas LIF treatment
led to no more than a 1.2 fold increase in the expression of
Osmrβ (Figure 1). At 9DIV, under the same conditions, the
addition of CNTF or LIF increased by 2.7 fold and 2.8 fold,
respectively, the expression of Osmrβ suggesting that the dif-
ference observed in the induction of Osmrβ at 6DIV reflects a
delay in the induction by LIF. Since OSM has been described
as being able to inhibit rod photoreceptor differentiation [13],
the CNTF-induced Osmrβ expression in post natal retina may
amplify CNTF effects.
The two clones, 10A and 2G, were, respectively homolo-
gous to glycyl t-RNA synthase (Gars) and Nuclear Receptor
coactivator 1 (Ncoa1). Real-time PCR failed to demonstrate
that these genes were significantly upregulated by CNTF or
LIF at 6DIV (Figure 1) even though they passed two differen-
tial screen tests.
Surprisingly, despite the quality of the UC6 subtraction,
our library failed to identify numerous genes up-regulated by
CNTF. This may be due either to the choice of highly strin-
gent conditions for subtraction or also the possibility of over-
all repression of transcription by CNTF. Previous studies based
on analysis of transcriptomic changes in the CNS after CNTF
treatment have demonstrated that, as in this study, CNTF
mostly induced glial genes [30]. However since we aimed at
identifying genes promoting rod photoreceptor differentiation,
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TABLE 3. GENES ISOLATED BY SUBTRACTIVE SUPPRESSIVE HYBRIDIZATION IN A DC6 (DOWNREGULATED BY CILIARY NEUROTROPHIC FACTOR AFTER
SIX DAYS IN VITRO) LIBRARY
                                                              Accession
Clone    bp               Blast result            Symbol       number       Homo    Status
-----   ----   --------------------------------   -------   ------------   ------   ------
        GO: apoptosis
D2      284    Caspase-3                          Casp3     NM_012922      37912    V
A7      258    Bcl-2 associated transcription     Bclaf     XM_214967      8832     A
               factor
        GO : Regulation of gene expression
E2      693    Cone-Rod homeobox protein          Crx       NM_021855      467      V
F2      521    Bromodomain adjacent zinc          Baz2b     XM_229225      8394     A
               finger domain 2b
G4      574    t-complex associated testis        Tcte1l    NM_001013228   21304    no
               expressed 1 like
C5      369    Riken cDNA 1500031M22              Dimt1     XM_00106535    0 7047   R
D8      710    C21 ORF66 Isoform D                N/A       unknown        9604     R
        GO: Protein modification
D1      465    Ste-20 related kinase              Spak      AF099990       22739    A
C2      445    Ubiquitin Specific Peptidase 32    Usp32     NM_220798      13066    A
B6      688    Acidic nuclear phosphoprotein 32   Anp32e    NM_001013200   41519    A
               family member E
B2      290    Protein tyrosine phosphatase       Ptpip51   BC082081       34926    A
               interracting protein
G7      1036   Epm2a interracting protein         Epm2aip   XM_236659      8875     A
D4      240    Riken cDNA 5330408N05 gene         N/A       XM_23000       36420    R
        GO: Protein localization
C7      490    Translocation protein 1            Tloc1     BC099207       2449     A
        GO : signal transduction
A2      501    ADP-ribosylation factor 4          Arf4      NM_024151      55593    A
F11     350    Homolog to TBC1 Domain family      Tbc1d15   XM_345825      11249    R
               mb 15
        GO: Cell Ion Homeostasis
F5      670    Iron Responsive Element            Ireb2     NM_022863      11280    no
               Binding protein 2
DC6 subtraction suppressive hybridization library was generated using RNA from control explants as driver and the RNA from six days in
vitro (6DIV)-ciliary neurotrophic factor treated explants as tester. Clone represents the cDNA number in the library; bp denotes the size in base
pair of the cDNA; blast result indicates the published sequence identical to the clone sequence Symbol, Accession number, and Homologene
refer to the available on-line datas for the published sequence. Status represents the cDNA characterization in this study: A for analyzed, R for
rejected, no for gene that didn’t exhibit gene expression variation, and V for gene validating the library. cDNA were classified accordingly to
their gene ontology (GO).
210we next focused our study on genes isolated in the DC6 li-
brary.
Identification of genes isolated from DC6 library:  After
DC6 library screening, 21 cDNAs were isolated, sequenced,
and submitted to on-line databases with the aim of identifying
known or predicted genes or EST contigs (Table 3). A few
cDNAs were identical to the same gene: D2, F8, C1, C11 cor-
responding to caspase-3 and A7 and G8 to the Bcl-2-associ-
ated transcription factor.
All genes were classified accordingly to their GOA in five
functional categories: two cDNAs corresponded to apoptosis
(D2, A7), five to regulation of gene expression (E2, F2, G4,
C5, D8), six to protein modification (D1, C2, B6, B2, G7,
D4), one to protein localization (C7), 2 to signal transduction
(A2, F11), and 1 to cell ion homeostasis process (F5). In addi-
tion, cDNAs may have had overlapping functions such as B2,
which is involved in protein modification and in apoptosis
and A7, in regulation of gene expression and regulation of
apoptosis (Table 3). Among the 17 different cDNAs, 13 cor-
responded to identified genes. Of the remaining, one had simi-
larity with a domain homolog of Rab-GAP protein (F11), and
three failed to match with any known cDNAs although they
showed partial homologies with known domains that enabled
their classification using the GOA (C5, D8, and D4). In view
of the poor reliability of the data sequences, we decided to
exclude these latter four clones from further analyses.
As for UC6 cDNAs, expression of the 13 remaining
cDNAs from DC6 library was first assayed by real-time PCR
amplification of RNA from rat retinal explants. The explants
were cultured with or without CNTF or LIF for 6 DIV to con-
firm their down-regulation by these cytokines (Figure 3A).
Among the selected cDNAs, 11 reached a minimum inhibi-
tion of 25% at day 6 of cytokine treatment (with a mean value
of 47% of inhibition) whereas 2 cDNAs were not or were
poorly down-regulated by CNTF or LIF after 6DIV. These
two clones, F5 (IREB2 for iron responsive element binding
protein 2) and G4 (TCTE1L for t-complex associated testis
expressed 1 like) were therefore discarded from further ex-
pression analysis. Noteworthy, E2 and D2, which corre-
sponded, respectively, to cone rod homeobox protein (CRX),
a transcription factor involved in photoreceptor differentia-
tion [31], and to the apoptotic effector, Caspase-3, were
downregulated at 6DIV after addition of CNTF or LIF. Crx
expression was two- and nine fold lower in CNTF- and LIF-
treated explants, respectively, compared to control explants,
whereas Caspase-3 expression was decreased by 30% and 21%
in CNTF- and LIF-treated explants, respectively, compared to
control explants (Figure 3A). The isolation of Crx, and
Caspase-3 as downregulated genes is consistent with CNTF-
inhibited photoreceptor differentiation [13,15,32] as well as
the neuroprotective effect of CNTF on different models of
retinal degeneration [12] and therefore demonstrates the qual-
ity of the DC6 subtraction.
To redefine the cell type specificity of the nine candidate
cDNAs, photoreceptor specific expression was assayed using
RNA extracted from a photoreceptorless retina. The expres-
sion of the nine cDNAs was quantified in adult dystrophic
RCS rat by real time PCR and compared to the expression in
an adult nondystrophic control RCS strain. The persistence of
cDNA expression in a dystrophic retina reflects expression in
the inner part of this tissue. Therefore the ratio of expression
of one cDNA in rat retina between the two RCS strains is pro-
portional to its expression in the outer nuclear layer. To con-
firm the degeneration of photoreceptors in dystrophic RCS
rat, we performed the quantification of rhodopsin, a rod-spe-
cific protein. In this case, as expected, rhodopsin expression
was 12.9 fold lower in the retina of dystrophic animals com-
pared to control RCS rat retina (Figure 3B). Eight cDNAs
showed lower expression in dystrophic RCS rat retina than in
control RCS rat retina with a mean value of 2 fold. The ex-
pression of the cDNA corresponding to A2 was 1.3 fold higher
in dystrophic RCS rat than in control RCS rat retina. The level
of expression in Müller cells was assayed by real-time PCR
using RNA extracted from pure retinal Müller glial cell cul-
tures [19]. The expression of vimentin, a well documented
marker of Müller cells [19,33], was arbitrarily fixed at 10,000
u.a. and the expression of the nine cDNAs ranged from 6 to
1255 u.a. (Figure 3C). cDNAs were classified in three groups
based on their level of transcription compared to the expres-
sion of vimentin: Low, (500 fold less transcript detected than
vimentin transcript), including F2, D1 and G7, intermediate
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Figure 1. Relative level of UC6 cDNAs expression in retinal explants
after six days of cytokine treatment.  Retinal explants from P0 rat
were cultured for six days in vitro (DIV) with medium alone (white
bars) or with 10 ng/ml of either ciliary neurotrophic factor (red bars)
or leukemia inhibitory factor (black bars). Retinal explants were har-
vested after 6DIV and RNA were extracted. cDNA expression corre-
sponding to each clone was analyzed by real-time RT-PCR experi-
ments. Histogram illustrates the mRNA expression corresponding to
9H, 6H, 4F, 2G, and 10A clones normalized by S26. For each gene,
all values were compared to mRNA expression of untreated rat reti-
nal explants at 6DIV. Data are expressed as mean±SD from two in-
dependent experiments performed in triplicate. (***p<0.001;
**p<0.01; *p<0.05).
211(50 fold), including C2, B6, B2, and C7, and high (five fold),
including A7 and A2 (Figure 3C).
The kinetics of regulation by CNTF and LIF of the nine
selected DC6 cDNAs was therefore analyzed on explants for
9 DIV and during in vivo retinal development. Explants were
cultured with or without CNTF or LIF in conditions similar to
those used for library. Following varying time-points in cul-
ture (1, 3, 6, and 9DIV) explants were collected and their RNAs
were isolated and quantified by real-time PCR amplification.
Similarly, RNAs were collected from rat retina from P0 to
P18 and adulthood and were subjected to reverse transcrip-
tion followed by real-time PCR amplification. Results are pre-
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Figure 2. Glial fibrillary acidic protein induction in retinal explants after six days of cytokine treatment.  P0 retinal explants were cultured with
medium alone (control; A-C) or supplemented with 10 ng/mL of either ciliary neurotrophic factor (D-F) or leukemia inhibitory factor (G-I).
After six days in vitro (6DIV) of culture, explants were fixed and stained with anti-glial fibrilary acidic protein (green). Gcl represents
ganglion cell layer; inl represents inner nuclear layer; and onl stands for outer nuclear layer. Scale bar equals 40 µm.
212sented in Figure 4. Each DC6 cDNA is described in the fol-
lowing section; cDNAs are listed according to their gene on-
tology.
Apoptosis:  In addition to Caspase-3, a second gene in-
volved in apoptosis, Bcl-2 associated transcription factor
(Bclaf), was isolated in the DC6 library (clone A7). Bclaf, also
named Btf, was identified in two separate yeast two-hybrid
screens: one using E1B 19K, an anti-apoptotic protein from
adenovirus [34] and the second against Emerin, an integral
nuclear membrane protein, involved in the Emery-Dreifuss
muscular dystrophy [35]. BCLAF is considered a death-pro-
moting transcriptional repressor, depending on its subcellular
localization: It represses transcription when localized in the
nucleus and acts as a proapoptotic protein when localized in
the cytoplasm where it binds to the BCL-2 family members
and inhibits their anti-apoptotic activity [34,35].
Real-time PCR experiments on retinal explants confirmed
that Bclaf expression was downregulated by CNTF (Figure 4,
A7). At 6DIV, corresponding to the time chosen for mRNA
subtraction, the inhibition of Bclaf expression by CNTF or
LIF reached a maximum. At this time-point, Bclaf expression
was inhibited by 26% and 54% after CNTF or LIF treatment,
respectively, when compared to control retinal explants (Fig-
ure 3A). Analysis of temporal expression of Bclaf during post-
natal retinal development showed that its expression level re-
mained stable from P0 to adulthood (Figure 4, A7). Bclaf ex-
pression in dystrophic RCS rat was 1.3 fold lower than in con-
trol (Figure 3B). Bclaf was estimated to be highly expressed
by Müller cells (Figure 3C). Taken together, these results sug-
gested that BCLAF is not photoreceptor specific.
In this context, the CNTF-downregulated expression of
Bclaf may be one mechanism by which CNTF mediates its
neuroprotective effect. Kasof et al. have described BCLAF as
a protein that may be involved in the repression of transcrip-
tion of survival factors [34]. Therefore, the inhibition of ex-
pression of Bclaf by CNTF may lead to the expression of Bclaf-
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Figure 3. Relative level of DC6 cDNAs expression after six days of cytokine treatment, in RCS rat retina and in Müller glial cell cultures.  A:
Retinal explants from P0 rat were cultured with medium alone (white bars) or with 10 ng/ml of either CNTF (red bars) or LIF (black bars).
Retinal explants were harvested after 6DIV and RNA were extracted. cDNA expression corresponding to 13 clones (F5, G4, E2, D2, A7, F2,
D1, C2, B6, B2, G7, C7, and A2) isolated from DC6 library was analyzed by real-time RT-PCR experiments. For each gene, all values were
compared to mRNA expression of untreated rat retinal explants at 6DIV. Data are expressed as mean±SD from two independent experiments
performed in triplicate. (***p<0.001; **p<0.01; *p<0.05) B: Retinas from control RCS rat (white bars) and dystrophic RCS rat (black bars)
were collected at three months and RNA extracted. cDNA expression corresponding to rhodopsin and to nine clones (A7, F2, D1, C2, B6, B2,
G7, C7, and A2) isolated from the DC6 library and differentially expressed upon addition of CNTF or LIF, was analyzed by real-time PCR. For
each gene, all values were compared to mRNA expression of control RCS rat retina. Data are expressed as mean±SD from two independent
experiments performed in triplicate. (***p<0.001; **p<0.01; *p<0.05). C: RNA was extracted from pure retinal Müller cell culture and cDNA
expression corresponding to nine clones (A7, F2, D1, C2, B6, B2, G7, C7, and A2) analyzed by real-time PCR. The expression of vimentin
(Vim), a glial specific gene, was assessed as a control and arbitrarily fixed at 10,000 u.a. The cDNAs from DC6 library were classified in three
groups based on their level of transcription ranged from 6 to 1255 u.a.: Low (white bars, 500 fold less transcripts detected than vimentin
transcripts), Intermediate (Int; red bars, 50 fold) and high (black bars, 5 fold).
213repressed genes (such as Mdm-2 a potential p53 inhibitor) and
hence contribute to the neuroprotective effect of CNTF. Alter-
natively, it is worth noting that BCLAF may alter the cellular
localization and bioavailability of BCL2 and thus prevent its
anti-apoptotic activity [35]. Bclaf down-regulation by CNTF
could increase the amount of BCL2 able to bind Bcl-2-associ-
ated X protein (BAX) or other pro-apoptotic proteins thus sup-
porting the anti-apoptotic effects of CNTF.
Regulation of gene expression:  In addition to Crx, a sec-
ond cDNA potentially involved in the regulation of transcrip-
tion was identified. Clone F2 corresponded to bromodomain
adjacent to zinc finger domain 2B (Baz2b). Baz2b belongs to
a family of six bromodomain genes involved in chromatin-
dependent regulation of transcription [36]. Real-time PCR
performed on retinal explants treated with CNTF or LIF dem-
onstrated that following CNTF treatment the expression of
Baz2b was inhibited by approximately 20% and 10% at 1DIV
and 3DIV, respectively, compared to control explant cultures
and was inhibited by 60% at 6DIV and 9DIV. LIF treatment
achieved a comparable level of inhibition as CNTF at 1DIV
and 3DIV, however Baz2b expression was inhibited by 72%
and 56% at 6DIV and 9DIV compared to control retinal ex-
plants (Figure 4, F2). Analysis of Baz2b expression during
retinal development showed that its expression increased by
three fold from P0 to reach a plateau at P7 (Figure 4, F2). The
in vitro experiments demonstrated that Baz2b expression
reached a maximum during the differentiation of late retinal
progenitors, suggesting that it could play a role in photore-
ceptor, bipolar or Müller cell differentiation or maintenance.
The Baz2b expression was 3.2 fold lower in dystrophic RCS
rat retina than in control RCS rat retina and was poorly ex-
pressed in Müller glial cell transcripts (Figure 3B,C). Previ-
ous studies have demonstrated that CNTF injection in the
mature retina induced a chromatin remodelling in photore-
ceptor nuclei [37,38] even though Zeiss et al. failed to dem-
onstrate these changes [39]. Furthermore, preliminary studies
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Figure 4. Relative level of differential DC6
cDNA expression after six days of cytokine
treatment and during postnatal rat retinal de-
velopment.  Retinal explants from P0 rat were
cultured with medium alone (white bars) or
with 10 ng/ml of ciliary neurotrophic factor
(CNTF; red bars) or leukemia inhibitory fac-
tor (LIF; black bars). Retinal explants were
harvested after 1, 3, 6, and nine days in vitor
(9DIV) and RNA extracted. cDNA expression
corresponding to A7, F2, D1, C2, B6, B2, G7,
C7, and A2 clones was analyzed by real-time
RT-PCR. The histograms illustrate the mRNA
expression corresponding to each clone nor-
malized by S26. For each gene, all values were
compared to mRNA expression of untreated
rat retinal explants at 1DIV. Data are expressed
as mean + SD from two independent experi-
ments performed in triplicate. For each time
points, values of CNTF- or LIF-treated
samples were compared to time-matched con-
trol samples. All values were considered as
significant (p<0.05) except for those marked
NS (Not Significant). Rat retinas were har-
vested at P0, P3, P5, P7, P10, P14, P18, and
adulthood and the RNA extracted. cDNA ex-
pression corresponding to A7, F2, D1, C2, B6,
B2, G7, C7, and A2 clones was analyzed by
real-time RT-PCR. The curves illustrate one
representative experiment of the mRNA ex-
pression corresponding to each clone normal-
ized by S26. For each gene, all values were
compared to mRNA expression at P0.
214have demonstrated that BAZ2B could interact with imitation
switch (ISWI) [36]. ISWI is involved in chromatin remodel-
ing and in stem cell self-renewal [40]; its activity is depen-
dant upon the formation of the ATP-dependent chromatin as-
sembly and remodelling factor (ACF) complex composed of
ISWI and a BAZ family member. Morpholino studies have
revealed that ISWI regulates the expression of Pax6, Shh, Sox9,
and Bmp [41]. Furthermore a dominant negative mutant of
ISWI in Xenopus revealed profound retinal malformation in-
cluding aberrant ganglion cell layer formation and a drastic
reduction of photoreceptor cell number [41]. We could postu-
late that CNTF-induced disruption of Baz2b expression might
inhibit ACF activity, recapitulating the effect of the dominant
negative ISWI mutant and therefore participating in the inhi-
bition of photoreceptor differentiation by CNTF.
Protein modification:  Clone D1 corresponded to stk39, a
Ste20-related kinase (Spak) [42], a proline alanine-rich kinase
(Stk39) belonging to the GCK-VI subfamily of the Ste kinase
group [43,44]. Spak is expressed ubiquitously and has been
described as a regulator of the Na-K-Cl cotransporter (NKCC1)
in the central nervous system [44,45]. In explants treated with
CNTF or LIF, the inhibition of Stk39 expression peaked at 6
DIV. At this time-point, Stk39 expression was inhibited by
56% and 65% in retinal explants treated with CNTF or LIF,
respectively, compared to control. At 9DIV, CNTF or LIF treat-
ment inhibited the Stk39 expression by 53% and 56%, respec-
tively. Conversely, Stk39 expression during rat retinal devel-
opment was 4 fold higher at P7 than at P0 (Figure 4, D1) and
remained constant thereafter. The increase of Spak expression
following the differentiation of late retinal progenitors during
the first post natal week suggests that this protein could be
involved in the differentiation of these cells. D1 cDNA ex-
pression was 1.3 fold lower in dystrophic RCS retina com-
pared to control RCS retina, suggesting that it is not restricted
to photoreceptor cells in retina (Figure 3B). Real-time PCR
with cDNA transcripts from Müller cells suggested that D1
was poorly expressed in these cells (Figure 3C). The STE20
family has been reported to be involved in many biological
processes including cell cycle, apoptosis, homeostasis, and
stress response [43,44]: therefore, SPAK could be involved in
the regulation of these processes during retinal progenitor cell
differentiation. Consistently, mutations in Hippo, a member
of the GCK-II subfamily of Ste20, have been associated with
eye malformations due to an increase in proliferation and a
reduction in apoptosis [46].
Clone C2 corresponded to the ubiquitin specific pepti-
dase 32 (Usp32), also named Tre-2, a protein involved in the
deubiquitination pathway. It is described as an oncogene with
ability to transform mouse NIH 3T3 cells [47,48] and could
be regulated by Calcium/calmodulin complex [49]. Usp32
expression and function has not been described in the central
nervous system. Real-time PCR on retinal explants revealed a
maximum decrease of its expression upon addition of CNTF
or LIF at 3DIV and 6DIV. Usp32 expression was inhibited by
45% at 3DIV and 6DIV in CNTF-treated retinal explants com-
pared to control retina and 51% and 73% at 3 and 6DIV, re-
spectively, in LIF-treated retinal explants compared to con-
trol (Figure 4, C2). The level of expression increased during
retinal development to be maintained at a steady state in adult-
hood (Figure 4, C2). Usp32 expression was 1.6 fold lower in
dystrophic RCS compared to control RCS retina, while its
expression in Müller cell cultures was demonstrated as inter-
mediate (Figure 3B,C). Interestingly, faf, another member of
the USP family, regulates Drosophila ommatidia differentia-
tion through the deubiquitination of lqf, a specific protein in-
volved in the control of photoreceptor differentiation [50,51].
Similarly, USP32 could play a role in vertebrate retinal devel-
opment by modifying the half-life of key players in eye de-
velopment.
Clone B6 corresponded to the acidic leucine rich nuclear
phosphoprotein 32 family member e (Anp32e), also known as
Lanp-l or Cpd1 [52-54]. Anp32e seems to be expressed in sev-
eral tissues [55] including neurons where a specific isoform
of this protein was involved in synaptogenesis [56]. As shown
in Figure 4, B6 expression was inhibited at 6DIV by 35% and
62% in retinal explants treated with CNTF or LIF, respec-
tively, compared to control retinal explants; however no inhi-
bition was observed at 1 and 3 DIV. The maximum inhibition
by the CNTF family of cytokines was not reached until 9DIV,
with an inhibition of 56% and 37% after CNTF or LIF treat-
ment, respectively, when compared to control retinal explants
(Figure 4, B6). The analysis of the expression of Anp32e dur-
ing retinal development indicated that it began to be expressed
at P5 and increased until adulthood (Figure 4, B6). Anp32e
expression was 4.1 fold lower in dystrophic RCS rat retina,
compared to control RCS rat retina suggesting that Anp32e
transcripts are highly expressed in photoreceptor cells (Fig-
ure 3B) despite the intermediate level of expression detected
in Müller cells (Figure 3C). The absence of inhibition of
Anp32e expression by CNTF or LIF before 3DIV and the in-
hibition of expression thereafter may indicate that Anp32e is
involved in the maturation of the differentiated cells issued
from late progenitors rather than directly in progenitor cell
differentiation. This hypothesis is supported by the expres-
sion of Anp32e in photoreceptors and Müller cells as well as
its late developmental pattern of expression. Hence, ANP32E
may be involved in the final differentiation of photoreceptor
cells and in particular in the formation of the synapses in the
outer plexiform layer.
Clone B2 corresponded to the protein tyrosine phosphatase
interacting protein PTPIP51 and belongs to the family of so-
called T-cell protein tyrosine phosphatase-interacting protein
(TCPTPIP) [57]. This protein was recently described to be
expressed in the retina particularly in the photoreceptor and
the ganglion cell layers [57]. Ptpip51 inhibition by the CNTF
family of cytokine peaked at 6DIV. At this time-point, the
expression was inhibited upon addition of CNTF or LIF by
45% and 52%, respectively, compared to untreated retinal
explants (Figure 4, B2). The level of expression during retinal
development showed a biphasic increase of Ptpip51 transcripts,
from P0 to P7 and from P14 to P18 with constant level of
expression between P7 and P14. Interestingly, a closed kinetic
was observed in retinal explants with an increase of Ptpip51
expression from 1 to 6DIV and remained constant thereafter
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215(until 9DIV), similar to the in vivo plateau observed between
P7 and P14. The expression in retina was 2.1 fold lower in
dystrophic RCS rat compared to control RCS rat while the
expression was found to be intermediate in Müller cells (Fig-
ure 3B,C). A nuclear isoform of TCPTP is described to be
involved in the regulation of IL6-mediated signaling pathway
through STAT3 dephosphorylation [58]. The potential inter-
action of PTPIP51 with TCPTP in the retina might be a regu-
lator of the CNTF-activated STAT3, which has been previ-
ously reported in the postnatal retina [32,59,60]. In addition,
PTPIP51 has recently been described as a mitochondrial pro-
tein involved in the induction of apoptosis. In view of this
new function, the neuroprotective effect of CNTF might be
due to some extent to the CNTF-induced inhibition of Ptpip51
expression.
Clone G7 corresponded to Epm2a interacting protein
(EPM2AIP), which was identified in a yeast two-hybrid screen
using Laforin, also named EPM2A, as bait [61]. Mutations in
Laforin lead by an unknown mechanism to a rare autosomal
recessive disorder named Lafora disease characterized by an
impaired glycogen metabolism [62]. This pathology is char-
acterized by epilepsy, myoclonus, and progressive neurologi-
cal deterioration. EPM2AIP, the first partner of Laforin to be
identified, has no significant similarity with any known pro-
tein. No inhibition of its expression was observed at 1DIV
and 3DIV upon addition of either CNTF or LIF. In contrast,
the expression was inhibited by 54% and 36% at 6DIV and
9DIV, respectively, upon addition of CNTF compared to un-
treated retinal explants (Figure 4, G7). Similar results were
obtained with LIF treatment. Expression level during retinal
development demonstrated a 9 fold increase from P0 to adult-
hood (Figure 4, G7). Expression of Epm2aip in dystrophic
RCS retina was 1.4-fold lower than in control RCS retina and
Epm2aip was poorly expressed in Müller cells (Figure 3B,C).
Hence CNTF is capable of modulating Lafora activity in the
eye through regulation of Epm2aip expression. An understand-
ing of this regulation might be of use in the development of
new approaches to cure this orphan disease and in particular
in preventing the formation of Lafora bodies in the retina [63].
Protein localization:  Clone C7 corresponded to the trans-
location protein 1 gene (Tloc1) a homolog of Drosophila Dtrp1
and yeast Sec61p, for which a role in protein translocation
across and into the endoplasmic reticulum (ER) membrane
has been described [64]. Real-time PCR on retinal explants
did not reveal any decrease in Tloc1 expression upon addition
of CNTF or LIF at 1DIV and 3DIV. However, this expression
was inhibited by 16% and 53% after 6 and 9DIV, respectively,
in CNTF-treated retinal explants compared to control explants.
Tloc1 expression at 6 and 9DIV was inhibited by 26% and
33%, respectively, upon addition of LIF compared to untreated
retinal explants (Figure 4, C7). The level of expression in-
creased during retinal development and was maintained at a
steady state in adulthood (Figure 4, C7). Tloc1 expression in
dystrophic RCS rat was 0.8 fold lower in dystrophic retina
compared to control (Figure 3B) and was classified in the in-
termediate group for Müller expression (Figure 3C). TLOC1
is classified as a potential nonselective cation channel belong-
ing to the non-selective cation channel-2 (NSCC2) family.
Transient-receptor-potential like (TRPL) channel, a Na+, Ca2+
transporter belonging to this family, is implicated with another
Transient-receptor-potential (TRP) channel, in the depolariza-
tion of the drosophila photoreceptor membrane following light
absorption by rhodopsin as well as in the anchoring of the
transduction complex in rhabdomere [65]. Trp/trpl double
mutant drosophila are completely blind [65,66], however con-
stitutive TRP overexpression induces profound drosophila reti-
nal degeneration [67]. Cell death in these models could be
due to an increase or a decrease of Ca2+ influx. Conversely, in
mammals, TLOC1 activity may participate in Ca2+-toxicity
during retinal degeneration [68]. CNTF-downregulation of
Tloc1 expression may, in this context, facilitate a decrease in
intracellular Ca2+ imbalance and the subsequent rescue of pho-
toreceptors. Alternatively, together with the clone A2 described
below, TLOC1 may be involved in the general trafficking of
retinal proteins [64].
Signal transduction:  Clone A2 matched with ADP-
ribosylation factor 4 gene (Arf4). The ADP-ribosylation fac-
tor family is composed of six members distributed in three
classes and constitutes one family of the RAS superfamily
[69]. Arf4 is expressed in the retina, where it is involved in the
initial steps of the post golgi trafficking of rhodopsin [70].
Mutations that affect the rhodopsin sorting signal interfere with
interactions between Arf4 and rhodopsin, leading to an aber-
rant trafficking and the initiation of retinal degeneration [70].
Real-time PCR on rat retinal explants treated with or without
CNTF or LIF demonstrated that Arf4 expression was un-
changed at 1DIV or 3DIV by CNTF or LIF treatment. After
6DIV, Arf4 expression was decreased by 26% and 18% in
CNTF- and LIF-treated retinal explants, respectively, com-
pared to control retinal explants. At 9DIV, the inhibition of
ARF4 was similar to 6DIV, with an inhibition of 28% and
13% (Figure 4; A2). Real-time PCR on retinal cDNA demon-
strated that the Arf4 expression in dystrophic RCS rat was 1.3
fold higher than in control RCS rat (Figure 3A). Arf4 expres-
sion in Müller cells was classified as intermediate (Figure 3B).
Real-time PCR experiments failed to show any variation of
Arf4 expression from P0 to P18 nor any decrease after the full
differentiation of all retinal cell types. These results strongly
suggest that Arf4 is not exclusively transcribed by photore-
ceptors. This is in agreement with Deretic et al, who showed
expression of ARF4 thought the entire retina [70]. As in other
retinal diseases, the original genetic defect may be located in
a gene coding for a ubiquitous protein but the outstanding
metabolic activity of photoreceptor cells may lead to a photo-
receptor-only degeneration [71-73]. In light of our results, Arf4
is expressed in many cell types throughout retinal develop-
ment and may be necessary for the proper differentiation of
retinal cells. In this context, the downregulation of Arf4 could
disrupt the localization of rhodospin, leading to incomplete
differentiation of rod photoreceptors.
DISCUSSION
 CNTF is a potent inhibitor of photoreceptor cell differentia-
tion. Suppressive subtracted libraries were produced and
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216screened with the aim of identifying genes that can mediate
the biological activities of CNTF. Our screens have allowed
the characterization of several genes regulated by the CNTF
family of cytokines, one of which, pleiotrophin has already
been established as a regulator of photoreceptor and bipolar
cell differentiation [18]. An additional seven genes were char-
acterized as highly photoreceptor specific, such as Anp32e,
Baz2b, or Ptpip51 or involved in processes related to CNTF
activity. The activity of BCLAF and PTPIP51 implicates a
role for these proteins in apoptotic events. Furthermore, the
observed activity implies a role for USP32, ARF4, and SPAK
in controling the activity of key regulators of retinal develop-
ment by modifying their ubiquitination, localization, or phos-
phorylation, respectively. The majority of the selected genes
were downregulated by CNTF. Consistent with a role of CNTF
in adult neuroprotection, the regulation of apoptosis was the
category containing the most cDNA with seven different
clones. Hence, the mechanism of action of CNTF during de-
velopment may share similarity with the adult physiology of
this cytokine.
All clones selected in both libraries were regulated in the
same manner by CNTF and LIF, suggesting that regulation of
the DC6 and UC6 genes share a common regulation through
the gp130/LIFRβ complex. Noteworthy, in the case of the DC6
cDNA, six out of the nine cDNAs were regulated to a higher
extent by LIF than by CNTF. On the other hand, the induction
of Gfap expression by LIF was 1.5 fold lower than induction
by CNTF, reflecting a potentially lower glial response by LIF.
Taken together, LIF may be a better candidate for retinal neu-
ron survival and differentiation since it is able to induce a
greater regulation of gene transcription with a less detrimen-
tal glial response. These effects may be further enhanced since
the abundance of LIFRβ/gp130 receptor necessary for LIF
activity versus LIFRβ/gp130/CNTFRα complex required for
CNTF activity is in favor of the LIF response.
The correlation of the pattern of UC6 and DC6 cDNA
expression between in vitro explants and in vivo retinal de-
velopment observed in this study imply that the role of the
isolated candidates may be achieved ex vivo on retinal ex-
plants. We previously investigated pleiotrophin (clone 6H)
functions by misexpressing it in post-natal retinal explants,
and demonstrated that it both inhibited rod differentiation and
increased bipolar cell differentiation and thus participates in
CNTF-induced effects [18].
Finally our goal was to isolate new candidates with regu-
latory effects ranging from 25% to several-fold. In this con-
text, our approach using subtractive libraries has enabled the
characterization of many genes that would have been elimi-
nated from a broad analysis of the transcriptome, such as DNA
chips, where the cut-off is generally set to 2. Previous studies
have revealed many differences between the subtractive and
DNA chips approach, not only in the range of regulation but
also in the selected candidates [74]. DNA chip experiments
on retinal explants treated with LIF or CNTF are being under-
taken to complete these results and get a better view of the
kinetics of these cytokines using cluster analysis. Both ap-
proaches are necessary to achieve a comprehensive analysis
of the level of transcriptome variation induced by CNTF or
LIF and thus help to characterize the genetic programs
controling photoreceptor differentiation and survival.
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